▲ SURGE

Eterna Therapeutics Inc.

+42.6%
ERNANASDAQHealthcare2026-05-15
13.63
종가
9.56
전일 종가
+42.57%
변동률
2.9x
거래량 비율

급등 원인

관련 뉴스가 없습니다.

관련 뉴스

Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria
Weeklyvoice2026-04-13
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan2026-04-06
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus2026-04-06
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
Weeklyvoice2026-04-06
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular ...
Postregister2026-04-16

기술적 분석

시그널
볼린저 상단 돌파과매수MACD 강세SMA20 위
주요 지표
73.52RSI (14)
6.47SMA 20
0.34Bollinger Lower
12.60Bollinger Upper
6.47Bollinger Mid
1.58MACD
0.70MACD Signal
0.89MACD Hist
종목 상세 보기급등주 목록으로
Eterna Therapeutics Inc. +42.6% 급등 분석 (2026-05-15) | Alpha Lenz